American Society of Clinical Oncology

SHERPA: White

People

  1. Berger
    Berger
  2. Solit
    Solit
  3. Schultz
    Schultz
  4. Arcila
    Arcila
  5. Stadler
    Stadler
  6. Kris
    Kris
  7. Ladanyi
    Ladanyi
  8. Iyer
    Iyer
  9. Mandelker
    Mandelker
  10. Rudin
    Rudin

Groups

  1. GSK Faculty (23)
  2. Human Oncology and Pathogenesis Program (23)
  3. Department of Medicine (22)
  4. Solid Tumor Oncology Division (22)
  5. Genitourinary Oncology Service (17)
  6. Epidemiology and Biostatistics (16)
  7. Population Sciences Research Program (13)
  8. Center for Pancreatic Cancer Research (10)
  9. Gastrointestinal Oncology Service (10)
  10. Biostatistics Service (9)
Search Within
  1. "Michael Berger"
  2. "2018"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (5)
Groups
  1. GSK Faculty (23)
  2. Human Oncology and Pathogenesis Program (23)
  3. Department of Medicine (22)
  4. Solid Tumor Oncology Division (22)
  5. Genitourinary Oncology Service (17)
  6. Epidemiology and Biostatistics (16)

More Groups

People
  1. Michael Berger (23)
  2. David Solit (17)
  3. Nikolaus Schultz (9)
  4. Maria Arcila (8)
  5. Ahmet Zehir (7)
  6. Marc Ladanyi (7)

More People

Years
  1. 2018 (23)
Publications
  1. Journal of Clinical Oncology (22)
  2. JCO Precision Oncology (1)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PRECISE: A clinical-grade automated molecular eligibility screening and just-in-time (JIT) physician decision support solution for molecularly-selected oncology trials
    Meeting Abstract

    Tao, J.; Eubank, M. H.; Pamer, E.; Cangemi, N. A.; Drilon, A. E.; Harding, J. J.; Schram, A. M.; Smyth, L. M.; Jhaveri, K. L.; Li, B. T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clonal concordance and genomic heterogeneity in single CTC copy number alterations vs. paired IMPACT metastatic tissue sequencing from mCRPC patient samples
    Meeting Abstract

    Scher, H. I.; Dago, A. E.; Lee, J.; Sutton, R.; Graf, R. P.; Schreiber, N. A.; Hullings, M.; Wang, Y.; Landers, M. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of actionable cancer predisposing germline mutations in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • FOLFCIS regimen for treatment of cancer of the anal canal
    Meeting Abstract

    Mondaca, S.; Chatila, W. K.; Hechtman, J. F.; Bates, D.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Berger, M. F.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Plasma cell-free DNA for noninvasive molecular profiling in high-risk stage 4 neuroblastoma
    Meeting Abstract

    Kothari, P.; Yang, J.; Berger, M. F.; Shukla, N. N.; Modak, S.; Tsui, D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)
    Meeting Abstract

    Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)
    Meeting Abstract

    Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save